PPARG and Insulin resistance: A cross-sectional study in Iran among patients with T2DM showed that PPAR-γ Pro12Ala polymorphism was able to increase the effect of DII and DIL and that it is associated with metabolic syndrome, obesity, insulin resistance, hypertension, and an increase in inflammatory markers [38].